Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cleary

Showing results (311-320 of 445) with videos related to

Pageof 45
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2021
Opportunities for Utilization of DNA Repair Inhibitors in Homologous Recombination Repair-Deficient and Proficient Pancreatic AdenocarcinomaJames M Cleary, Brian M Wolpin, Stephanie K Dougan, et al.
NPJ Precision Oncology|September 2, 2022
Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinomaJames M Cleary, Betty Rouaisnel, Antoine Daina, et al.
Genetics|January 24, 2026
The SoyBase, LegumeInfo, and PeanutBase databases in support of legume research and crop improvementJacqueline D Campbell, Connor T Cameron, Alan M Cleary, et al.
Investigational New Drugs|November 18, 2016
A phase 1 study combining the HER3 antibody seribantumab (MM-121) and cetuximab with and without irinotecanJames M Cleary, Autumn J McRee, Geoffrey I Shapiro, et al.
Investigational New Drugs|June 12, 2014
A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumorsJames M Cleary, Caio Max S Rocha Lima, Herbert I Hurwitz, et al.
Communications Biology|March 29, 2024
Kir4.1 channels contribute to astrocyte CO<sub>2</sub>/H<sup>+</sup>-sensitivity and the drive to breatheColin M Cleary, Jack L Browning, Moritz Armbruster, et al.
Obstetrics and Gynecology|April 9, 2026
Latency of Hypertensive Disorders of Pregnancy and Cardiovascular Risk 2-7 Years After DeliverySwati Shree, Mindy Pike, Lynn M Yee, et al.
BMJ Open Sport & Exercise Medicine|June 20, 2022
Physical activity in older adults with metastatic gastrointestinal cancer: a pilot and feasibility studyJustin C Brown, Elizabeth Brighton, Nancy Campbell, et al.
Carbohydrate Research|August 25, 2009
Computational simulations of the Trichoderma reesei cellobiohydrolase I acting on microcrystalline cellulose Ibeta: the enzyme-substrate complexLinghao Zhong, James F Matthews, Peter I Hansen, et al.
Brain : a Journal of Neurology|April 17, 2023
Promyelinating drugs promote functional recovery in an autism spectrum disorder mouse model of Pitt-Hopkins syndromeJoseph F Bohlen, Colin M Cleary, Debamitra Das, et al.
Pageof 45

Showing results (311-320 of 445) with videos related to

Sort By:
Pageof 45
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2021
Opportunities for Utilization of DNA Repair Inhibitors in Homologous Recombination Repair-Deficient and Proficient Pancreatic AdenocarcinomaJames M Cleary, Brian M Wolpin, Stephanie K Dougan, et al.
NPJ Precision Oncology|September 2, 2022
Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinomaJames M Cleary, Betty Rouaisnel, Antoine Daina, et al.
Genetics|January 24, 2026
The SoyBase, LegumeInfo, and PeanutBase databases in support of legume research and crop improvementJacqueline D Campbell, Connor T Cameron, Alan M Cleary, et al.
Investigational New Drugs|November 18, 2016
A phase 1 study combining the HER3 antibody seribantumab (MM-121) and cetuximab with and without irinotecanJames M Cleary, Autumn J McRee, Geoffrey I Shapiro, et al.
Investigational New Drugs|June 12, 2014
A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumorsJames M Cleary, Caio Max S Rocha Lima, Herbert I Hurwitz, et al.
Communications Biology|March 29, 2024
Kir4.1 channels contribute to astrocyte CO<sub>2</sub>/H<sup>+</sup>-sensitivity and the drive to breatheColin M Cleary, Jack L Browning, Moritz Armbruster, et al.
Obstetrics and Gynecology|April 9, 2026
Latency of Hypertensive Disorders of Pregnancy and Cardiovascular Risk 2-7 Years After DeliverySwati Shree, Mindy Pike, Lynn M Yee, et al.
BMJ Open Sport & Exercise Medicine|June 20, 2022
Physical activity in older adults with metastatic gastrointestinal cancer: a pilot and feasibility studyJustin C Brown, Elizabeth Brighton, Nancy Campbell, et al.
Carbohydrate Research|August 25, 2009
Computational simulations of the Trichoderma reesei cellobiohydrolase I acting on microcrystalline cellulose Ibeta: the enzyme-substrate complexLinghao Zhong, James F Matthews, Peter I Hansen, et al.
Brain : a Journal of Neurology|April 17, 2023
Promyelinating drugs promote functional recovery in an autism spectrum disorder mouse model of Pitt-Hopkins syndromeJoseph F Bohlen, Colin M Cleary, Debamitra Das, et al.
Pageof 45